Singapore-based biotech firm ASLAN Pharma files for US listing

Singapore-based biotech firm ASLAN Pharma files for US listing

Singapore-based biopharma firm ASLAN Pharmaceuticals has filed for a proposed initial public offering (IPO) in the US to raise capital for clinical development of its products and trials.

The Taipei Exchange-listed company on Monday filed a registration statement with the Securities and Exchange Commission (SEC) for the proposed issue of its American Depository Shares (ADSs) on Nasdaq. In a statement, it said the number of ADSs to be offered, and the price range for the proposed offering are yet to be determined.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter